ALKBH5 and glioblastoma: In this work, we further investigated the imidazobenzoxazin-5-thione MV1035, and its ability to significantly reduce GBM U87-MG cell migration and invasiveness through inhibition of the RNA demethylase ALKBH5, as previously demonstrated [16].